Proactiveinvestors recommends
Additional Information
Market: AIM
Sector: Technology Hardware & Equipment
EPIC: AMP
Latest Price: 4.13p  (0,00%)
52-week High: 7.13p
52-week Low: 2.25p
Market Cap: 5.58M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Amphion Innovations
www.amphionplc.com

Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has a significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

Full Amphion Innovations profile here
Is AMP a Buy, Sell or Hold?Get your FREE analysis of AMP
Pdf

Amphion Innovations secures US$500,000 loan from chairman

3rd Feb 2012, 3:52 pm by Andre Lamberti The chairman’s unsecured loan financing to Amphion now totals US$4 million

Amphion Innovations (LON:AMP), the developer of medical and technology businesses, said it has secured additional unsecured loan financing of US$500,000 from its chairman James Macaleer.

Macaleer holds a 17.37 per cent stake in the company.

The loan is repayable on December 31 2013 and carries interest at 7 per cent per annum.

The chairman’s unsecured loan financing to Amphion now totals US$4 million, all with the same maturity and interest.

Macaleer will also receive 2 million warrants, expiring on December 2013, each entitling the holder to subscribe for one Amphion share at 8 pence.

This transaction is deemed a related party transaction for the purposes of the AIM Rules. As a result, the Independent Directors consider, having consulted with the Company's nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.